Opus Genetics IRD Common stock, shares authorized (in shares)
Common stock, shares authorized (in shares) at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's common stock, shares authorized (in shares).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's common stock, shares authorized (in shares)?
- Opus Genetics (IRD) reported common stock, shares authorized (in shares) of $125M in Q1 2026.
- How has Opus Genetics's common stock, shares authorized (in shares) changed year-over-year?
- Opus Genetics's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $125M to $125M.
- What is the long-term trend for Opus Genetics's common stock, shares authorized (in shares)?
- Over 5 years (2020 to 2025), Opus Genetics's common stock, shares authorized (in shares) has grown at a 10.8% compound annual growth rate (CAGR), from $75M to $125M.